Checklist: Pharma With A Purpose

Jazz Pharma is more than a company devoted to developing drugs for rare diseases and conditions, they're a company committed to compassion.
Posted on Jul 20, 2021 | 08:00am
Brought to you by Watch

Heard of Jazz Pharmaceuticals (NASDAQ GS: JAZZ)? If you haven't, perhaps that means you're lucky enough to not suffer from the types of complex conditions and rare diseases that are the focus of Jazz Pharma's global work. In many cases, the help offered by Jazz Pharma's line of prescription medicines are the only hope for patients. 

Among their multiple prescription medicines that are redefining what’s possible, Jazz Pharmaceuticals makes ZEPZELCATM (lurbinectedin) for the treatment of adults with a complex form of lung cancer called small cell lung cancer (SCLC). Jazz Pharma also makes Defitelio® (defibrotide sodium), the first and only approved treatment for hepatic veno-occlusive disease (VOD). And for the treatment of narcolepsy and obstructive sleep disorder,  Jazz Pharma's breakthrough SUNOSI promises a fuller, more energetic life.

Cutting edge pharmaceutical discoveries in the global marketplace aren't the only thing Jazz Pharma is about. They're also a company that strives for a healthy work environment, strong ethical standards, a commitment to diversity and inclusion, environmental and social integrity, corporate giving, access to education, and assistance for patients who can't afford their medicines. Now, don't you want to get to know Jazz Pharmaceuticals better?